SE7606913L - Orgnisk forening - Google Patents

Orgnisk forening

Info

Publication number
SE7606913L
SE7606913L SE7606913A SE7606913A SE7606913L SE 7606913 L SE7606913 L SE 7606913L SE 7606913 A SE7606913 A SE 7606913A SE 7606913 A SE7606913 A SE 7606913A SE 7606913 L SE7606913 L SE 7606913L
Authority
SE
Sweden
Prior art keywords
compounds
organic association
arabinofuranoxy
diamino
purine
Prior art date
Application number
SE7606913A
Other languages
Unknown language ( )
English (en)
Other versions
SE429656B (sv
Inventor
G B Elion
J E Riedout
R L Miller
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE7606913L publication Critical patent/SE7606913L/sv
Publication of SE429656B publication Critical patent/SE429656B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Artificial Filaments (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE7606913A 1975-06-17 1976-06-17 Analogiforfarande for framstellning av 9-(beta-d-arabinofuranosyl)purin-5?721-fosfater eller farmaceutiskt godtagbara salter derav SE429656B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25768/75A GB1562899A (en) 1975-06-17 1975-06-17 Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof

Publications (2)

Publication Number Publication Date
SE7606913L true SE7606913L (sv) 1976-12-18
SE429656B SE429656B (sv) 1983-09-19

Family

ID=10232986

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7606913A SE429656B (sv) 1975-06-17 1976-06-17 Analogiforfarande for framstellning av 9-(beta-d-arabinofuranosyl)purin-5?721-fosfater eller farmaceutiskt godtagbara salter derav

Country Status (17)

Country Link
US (1) US4136175A (sv)
JP (1) JPS52295A (sv)
AU (1) AU507515B2 (sv)
BE (1) BE843082A (sv)
CA (1) CA1052309A (sv)
CH (1) CH632771A5 (sv)
CS (2) CS192000B2 (sv)
DE (1) DE2627156A1 (sv)
DK (1) DK139727B (sv)
FI (1) FI61315C (sv)
FR (1) FR2361901A1 (sv)
GB (1) GB1562899A (sv)
HU (1) HU176046B (sv)
IL (1) IL49822A (sv)
NL (1) NL7606576A (sv)
SE (1) SE429656B (sv)
ZA (1) ZA763611B (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58763B2 (ja) * 1978-07-18 1983-01-07 三井造船株式会社 浮き防氷堤
EP0015584A3 (de) * 1979-03-12 1980-12-10 Kailash Kumar Dr. Prof. Gauri Neue Nukleotide, Verfahren zu ihrer Herstellung und Arzneimittel
US4357324A (en) * 1981-02-24 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
FR2518882A1 (fr) * 1981-12-30 1983-07-01 Pos Lab Composition therapeutique, a base de monophosphate d'inosine, pour le traitement des troubles d'accommodation de l'oeil
US4594415A (en) * 1982-03-29 1986-06-10 Robins Roland K Azole dinucleotide compositions and methods of use
DE3784655T2 (de) * 1986-12-18 1993-07-15 Kyowa Hakko Kogyo Kk Verfahren zur herstellung von ascorbinsaeure-2-phosphat.
ES2118752T3 (es) * 1990-06-27 1998-10-01 Ash Stevens Inc Procedimiento para la preparacion de 9-beta-d-arabinofuranosil-2-fluoroadenina-5'-fosfato.
US5866429A (en) * 1991-04-03 1999-02-02 Bloch; Will Precision and accuracy of anion-exchange separation of nucleic acids
US6319908B1 (en) * 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
TW593331B (en) * 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
US6872710B2 (en) * 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US8557868B2 (en) * 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
US20070098813A1 (en) * 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions with a peroxide source and a preservative
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
JP5258139B2 (ja) * 2000-11-08 2013-08-07 エフエックスエス・ベンチャーズ・エルエルシー ビタミンｂの形態を含有する改良した眼科用およびコンタクトレンズ用溶液
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
US9492582B2 (en) * 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
US20060148665A1 (en) * 2000-11-08 2006-07-06 Bioconcept Laboratories Ophthalmic and contact lens solutions containing forms of vitamin b
AU2720602A (en) * 2000-11-08 2002-05-21 Bio Concept Lab Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US6624203B1 (en) * 2001-11-08 2003-09-23 Francis X. Smith Nucleic acid bases used in ophthalmic solutions
US20040127435A1 (en) * 2002-08-02 2004-07-01 Regents Of The University Of California Uses for inhibitors of inosine monophosphate dehydrogenase
US7939501B2 (en) * 2003-04-15 2011-05-10 Smith Francis X Ophthalmic and contact lens solutions containing peptides as preservative

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328389A (en) * 1964-08-07 1967-06-27 Sankyo Co Process for preparing nucleotide derivatives
US3300478A (en) * 1965-06-01 1967-01-24 Upjohn Co Arabinofuranosyl 2', 5'-and 3'-5'-dinucleoside phosphates and process therefor
US3382232A (en) * 1965-08-26 1968-05-07 Takeda Chemical Industries Ltd Method for the production of 5'-ribonucleotide
US3337530A (en) * 1965-09-20 1967-08-22 Upjohn Co Dinucleoside 3', 5' -and 2', 5'-phosphates containing one 7-deazapurin riboside moiety
US3448098A (en) * 1966-09-27 1969-06-03 Merck & Co Inc Production of guanylic acid
BE756704A (fr) * 1969-09-26 1971-03-01 Parke Davis & Co Procede de production du 5'-phosphate de 9-(beta-d- arabinofuranosyl) adenine et de ses sels
BE759011A (fr) * 1969-11-17 1971-05-17 Wellcome Found Aminopurines
GB1386584A (en) * 1970-11-16 1975-03-12 Wellcome Found Method of preparation of purine sugar derivatives
GB1386585A (en) * 1970-11-16 1975-03-12 Wellcome Found Purine sugar derivatives
JPS5046696A (sv) * 1973-03-19 1975-04-25

Also Published As

Publication number Publication date
CA1052309A (en) 1979-04-10
DE2627156A1 (de) 1977-01-13
CS191976B2 (en) 1979-07-31
DK139727C (sv) 1979-09-17
FI61315C (fi) 1982-07-12
DK139727B (da) 1979-04-02
JPS52295A (en) 1977-01-05
DK271876A (sv) 1976-12-18
AU1500476A (en) 1977-12-22
IL49822A (en) 1979-11-30
FI761759A (sv) 1976-12-18
FR2361901B1 (sv) 1978-12-15
SE429656B (sv) 1983-09-19
US4136175A (en) 1979-01-23
GB1562899A (en) 1980-03-19
AU507515B2 (en) 1980-02-21
BE843082A (fr) 1976-12-17
CS192000B2 (en) 1979-07-31
FI61315B (fi) 1982-03-31
FR2361901A1 (fr) 1978-03-17
ZA763611B (en) 1978-01-25
CH632771A5 (de) 1982-10-29
HU176046B (en) 1980-11-28
NL7606576A (nl) 1976-12-21

Similar Documents

Publication Publication Date Title
SE7606913L (sv) Orgnisk forening
NO158539C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktiv 2,6-diaminopurinforbindelse.
FR1463543A (fr) Dérivés d'acides phosphoniques, leur préparation et leurs applications
ES468475A1 (es) Procedimiento para la preparacion de derivados de cefem
FI872864A0 (sv) Förfarande för framställning av farmaceutiskt aktiva bensimidazolföreningar
NO176356C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive pyrazolopyridinforbindelser
ATE20748T1 (de) Guaninderivate.
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
ES475035A1 (es) Un procedimiento para preparar derivados del acido cefalosporanico.
GB1478563A (en) Rifamycin derivatives
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
BE616919A (fr) Procédé de préparation de dérivés d'acides
IT8025159A0 (it) Preparato medicinale ad azione citostatica, nonche' derivati dell'acido isocianurico eprocedimento per la loro preparazione.
BE856319A (fr) Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite
SE7702232L (sv) Forfarande for framstellning av substituerade 8-azapurinderivat
FR2378026A1 (fr) Medicaments contenant des derives de sulfure d'hydroxymethyl-2 amino-2' diphenyle
GB1184044A (en) Nitrofuryl-Oxadiazole Derivatives
FR2430230A1 (fr) Medicaments a base de derives de l'acide anthranilique
GB1155529A (en) Imidazole derivatives, their Preparation and Compositions containing them
NO167982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater.
GB1077249A (en) A new amine and process for its manufacture
GB1059174A (en) Diazacycloalkane derivatives
SE8001981L (sv) Kompositioner for behandling av glaukom
IT1215238B (it) Derivati di omocisteina tiolattone,loro procedimento di preparazione e formulazioni farmaceutiche
SE7610968L (sv) Forfarande for framstellning av biologiskt aktiva di-karboxylsyraderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7606913-7

Effective date: 19880318

Format of ref document f/p: F